 CAMBRIDGE, Mass., Sept. 14, 2021 GLOBE NEWSWIRE -- Checkmate Pharmaceuticals Inc. NASDAQ: CMPI Checkmate, a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the Cantor Virtual Global Healthcare Conference on Thursday, September 30 from 10:40-11:10am ET. Checkmate will also host 1x1 investor meetings during the conference. 